Omeprazole in infants with cimetidine-resistant peptic esophagitis

J Pediatr. 1998 Feb;132(2):352-4. doi: 10.1016/s0022-3476(98)70460-3.

Abstract

Twelve neurologically normal infants (age 2.9+/-0.9 months) with peptic esophagitis (grade 2) who did not respond to cimetidine (in addition to positioning, cisapride, and Gaviscon) were treated with omeprazole, 0.5 mg/kg once a day, for 6 weeks. The effectiveness of omeprazole was evaluated in all infants by clinical assessment and endoscopy before and after treatment and by 24-hour gastric pH monitoring during treatment in seven infants. Omeprazole therapy led to a marked decrease in symptoms, endoscopic and histologic signs of esophagitis, and intragastric acidity.

MeSH terms

  • Anti-Ulcer Agents / therapeutic use*
  • Cimetidine / therapeutic use
  • Esophagitis, Peptic / drug therapy*
  • Histamine H2 Antagonists / therapeutic use
  • Humans
  • Infant
  • Omeprazole / therapeutic use*
  • Treatment Failure
  • Treatment Outcome

Substances

  • Anti-Ulcer Agents
  • Histamine H2 Antagonists
  • Cimetidine
  • Omeprazole